Aldeyra Therapeutics Inc. (ALDX)
undefined
undefined%
At close: undefined
4.90
-0.81%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11
Revenue - - - - - - - - - - - - -
Cost of Revenue 262.78K 258.71K 264.18K 56.22K 96.31K 71.00K 37.85K 35.79K 18.78K - - - -
Gross Profit -262.78K -258.71K -264.18K -56.22K -96.31K -71.00K -37.85K -35.79K -18.78K - - - -
Operating Income -42.79M -62.68M -56.22M -36.42M -63.07M -39.70M -22.49M -18.70M -11.99M -7.27M -3.68M -1.11M -2.11M
Interest Income 7.32M 2.35M 185.36K 292.22K 1.54M 952.70K 261.25K 102.04K 11.13K 3.00 31.00 101.00 5.00K
Pretax Income -37.54M -62.02M -57.78M -38.03M -62.14M -38.89M -22.34M -18.70M -12.09M -5.19M 13.06M -23.07M -2.38M
Net Income -37.54M -61.37M -59.25M -37.55M -60.83M -38.89M -22.34M -18.70M -12.09M -5.19M 13.06M -23.07M -2.38M
Selling & General & Admin 13.34M 15.37M 11.28M 9.99M 12.15M 9.88M 6.19M 5.52M 4.41M 3.56M 2.13M 644.94K 743.94K
Research & Development 29.46M 47.31M 44.94M 24.68M 44.35M 29.82M 16.30M 13.18M 7.57M 3.71M 1.54M 469.27K 1.36M
Other Expenses - - - - - - - - - 2.33M 720.78K -21.48M 5.41K
Operating Expenses 42.79M 62.68M 56.22M 34.67M 56.51M 39.70M 22.49M 18.70M 11.99M 7.27M 3.68M 1.11M 2.11M
Interest Expense 2.07M 1.69M 1.74M 1.90M 603.85K 146.79K 113.45K 105.51K 112.31K 244.17K 159.32K 342.01K 279.93K
Selling & Marketing Expenses - - - - - - - - - - - - -
Cost & Expenses 42.79M 62.68M 56.22M 34.67M 56.51M 39.70M 22.49M 18.70M 11.99M 7.27M 3.68M 1.11M 2.11M
Income Tax - -655.35K 1.48M -479.26K -1.31M 952.70K 223.40K 66.25K -7.65K 243.10K 159.29K -21.14M 285.34K
Shares Outstanding (Basic) 58.94M 58.41M 54.04M 33.97M 27.11M 21.69M 15.92M 11.35M 8.63M 3.82M 327.37K 4.04M 327.37K
Shares Outstanding (Diluted) 58.94M 58.41M 54.04M 33.97M 27.11M 21.69M 15.92M 11.35M 8.63M 3.85M 4.80M 4.52M 4.80M
EPS (Basic) -0.64 -1.05 -1.1 -1.11 -2.24 -1.79 -1.4 -1.65 -1.4 -1.36 39.90 -5.72 -7.26
EPS (Diluted) -0.64 -1.05 -1.1 -1.11 -2.24 -1.79 -1.4 -1.65 -1.4 -1.35 2.72 -5.1 -0.5
EBITDA -35.21M -60.07M -55.77M -36.07M -61.44M -38.68M -22.19M -18.56M -11.96M -4.94M 13.22M -22.73M -2.10M
Depreciation & Amortization 262.78K 258.71K 264.18K 56.22K 96.31K 71.00K 37.85K 35.79K 18.78K 1.07K 31.00 3.74K 1.59K